X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (804) 804
Publication (57) 57
Book Review (32) 32
Book / eBook (6) 6
Conference Proceeding (3) 3
Magazine Article (3) 3
Book Chapter (1) 1
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (657) 657
zoledronic acid (484) 484
index medicus (434) 434
female (426) 426
diphosphonates - administration & dosage (395) 395
bisphosphonates (329) 329
diphosphonates - therapeutic use (325) 325
male (319) 319
diphosphonates - adverse effects (289) 289
infusions, intravenous (280) 280
osteoporosis (280) 280
bone density conservation agents - administration & dosage (275) 275
middle aged (262) 262
aged (258) 258
bone density conservation agents - therapeutic use (253) 253
imidazoles - administration & dosage (246) 246
bone density conservation agents - adverse effects (209) 209
oncology (183) 183
imidazoles - therapeutic use (179) 179
bone neoplasms - secondary (173) 173
imidazoles - adverse effects (165) 165
endocrinology & metabolism (161) 161
bone neoplasms - drug therapy (151) 151
injections, intravenous (150) 150
treatment outcome (150) 150
double-blind (144) 144
pamidronate (136) 136
fractures (125) 125
bones (123) 123
adult (121) 121
care and treatment (119) 119
intravenous administration (116) 116
risk factors (116) 116
alendronate (115) 115
administration, oral (113) 113
osteoporosis - drug therapy (113) 113
bone density - drug effects (107) 107
cancer (107) 107
therapy (107) 107
aged, 80 and over (104) 104
osteonecrosis (104) 104
medicine & public health (103) 103
bisphosphonate (102) 102
drug therapy (98) 98
drug administration schedule (94) 94
bone (93) 93
multiple-myeloma (93) 93
orthopedics (93) 93
postmenopausal women (92) 92
bone-mineral density (91) 91
dentistry, oral surgery & medicine (88) 88
diphosphonates (87) 87
postmenopausal osteoporosis (86) 86
breast neoplasms - pathology (85) 85
breast-cancer (85) 85
bone metastases (84) 84
research (81) 81
skeletal complications (81) 81
risk-factors (79) 79
osteoporosis, postmenopausal - drug therapy (78) 78
bone density (77) 77
rheumatology (76) 76
dentistry (75) 75
osteonecrosis - chemically induced (75) 75
phosphonates (75) 75
diphosphonates - pharmacology (72) 72
breast cancer (70) 70
medicine, general & internal (70) 70
metastasis (70) 70
necrosis (70) 70
surgery (70) 70
clinical trials (69) 69
placebo-controlled trial (69) 69
prevention (69) 69
intravenous pamidronate (68) 68
ibandronate (66) 66
pharmacology & pharmacy (65) 65
bone mineral density (64) 64
child (64) 64
retrospective studies (64) 64
breast neoplasms - drug therapy (63) 63
time factors (63) 63
follow-up studies (62) 62
animals (61) 61
health aspects (61) 61
jaw (59) 59
analysis (58) 58
abridged index medicus (57) 57
double-blind method (57) 57
pain (57) 57
women (57) 57
jaw diseases - chemically induced (55) 55
children (54) 54
denosumab (53) 53
patients (53) 53
intravenous zoledronic acid (52) 52
osteogenesis imperfecta (52) 52
risedronate (52) 52
endocrinology (51) 51
randomized controlled trials as topic (51) 51
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (782) 782
German (7) 7
Japanese (7) 7
Chinese (3) 3
Italian (3) 3
Dutch (2) 2
French (2) 2
Spanish (2) 2
Hungarian (1) 1
Korean (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 18, pp. 1799 - 1809
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 18, pp. 1714 - 1723
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 1989 - 1999
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 03/2011, Volume 26, Issue 3, pp. 503 - 511
Clinical data suggest concomitant therapy with bisphosphonates and parathyroid hormone (PTH) may blunt the anabolic effect of PTH; rodent models suggest that... 
ZOLEDRONIC ACID | INFUSION | TERIPARATIDE | BISPHOSPHONATE | OSTEOPOROSIS | Bisphosphonate | teriparatide | infusion | osteoporosis | zoledronic acid | BONE-MINERAL DENSITY | PARATHYROID-HORMONE 1-34 | ALENDRONATE | WOMEN | FRACTURE | BISPHOSPHONATES | THERAPY | CANCELLOUS BONE | MASS | ENDOCRINOLOGY & METABOLISM | PROXIMAL FEMUR | Collagen Type I - blood | Peptides - blood | Injections, Intravenous | Teriparatide - therapeutic use | Bone Density - physiology | Follow-Up Studies | Humans | Middle Aged | Osteoporosis, Postmenopausal - complications | Imidazoles - administration & dosage | Osteoporotic Fractures - drug therapy | Bone Remodeling - physiology | Injections, Subcutaneous | Peptide Fragments - blood | Diphosphonates - therapeutic use | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Osteoporotic Fractures - physiopathology | Diphosphonates - adverse effects | Biomarkers - metabolism | Bone Density Conservation Agents - adverse effects | Teriparatide - administration & dosage | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Diphosphonates - administration & dosage | Procollagen - blood | Bone Density Conservation Agents - administration & dosage | Osteoporosis, Postmenopausal - drug therapy | Osteoporosis, Postmenopausal - blood | Osteoporotic Fractures - complications | Least-Squares Analysis | Osteoporosis, Postmenopausal - physiopathology | Teriparatide - adverse effects | Aged | Osteoporotic Fractures - blood
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 08/2012, Volume 71, Issue 8, pp. 1322 - 1328
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 10/2002, Volume 94, Issue 19, pp. 1458 - 1468
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2005, Volume 353, Issue 9, pp. 898 - 908
Journal Article